Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/IRLAB-THERAPEUTICS-AB-61747292/news/IRLABs-bahnbrechende-Phase-IIb-Studie-mit-Pirepemat-React-PD-liefert-neue-Erkenntnisse-uber-ein-45889951/?utm_source=whatsapp&utm_medium=social&utm_campaign=share